Form 8-K - Current report:
SEC Accession No. 0001437749-26-023764
Filing Date
2026-07-17
Accepted
2026-07-17 16:15:27
Documents
14
Period of Report
2026-07-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20260716_8k.htm   iXBRL 8-K 42216
2 EXHIBIT 10.1 ex_989227.htm EX-10.1 104915
3 EXHIBIT 10.2 ex_989228.htm EX-10.2 59983
  Complete submission text file 0001437749-26-023764.txt   380415

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA sdev-20260715.xsd EX-101.SCH 3579
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sdev-20260715_def.xml EX-101.DEF 11424
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE sdev-20260715_lab.xml EX-101.LAB 15310
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sdev-20260715_pre.xml EX-101.PRE 11584
17 EXTRACTED XBRL INSTANCE DOCUMENT nby20260716_8k_htm.xml XML 2860
Mailing Address 222 LAKEVIEW AVE, SUITE 800 WEST PALM BEACH FL 33401
Business Address 222 LAKEVIEW AVE, SUITE 800 WEST PALM BEACH FL 33401 561-206-4345
Stablecoin Development Corp (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 261183905
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)